#pecoma

People are suffering from aproblem with PEComa. It is an Advanced   Malignant Perivascular Epithelioid Cell Cancer. Are you a resident of America?  If yes, then you are welcome to the PEComa clinical trial for research and get  the advance diagnosis system. You are well known about the PEComaand now know more  about the diagnosis and the treatment.

Diagnosis of PEComa

PEComa diagnosis depends upon several factors. If you are a PEComapatient, then you have to be careful about few  things before clinical trials of the advance Pecoma Treatment research&  study.

 The patient must have made ametastatic or advanced diagnosis before,and they need to confirm that they can’t go for  surgery anymore.

 Patient must have the maintained blood level as per  research norm.

 Radiotherapy, chemotherapy, surgery and other advanced  therapy are allowed if it can be completed within  28 days of enrollment.

 Age of patient must be more than 18 years for all sex.

 Investigating doctor must confirm that you are  suffering from Malignant Epithelioid Cell Cancer.

 Patient must ensure that patient can walk and can  participate in physical activity.

First of all, CT scan, MRI will be  done on the basis of malignancy. When adoctoridentifies  the sign and affected region, then abiopsy  will be done upon atumour to get the  confirm diagnosis.

PEComa treatment

 Depend upon the malignancy, PEComa  will be treated. Most of PEComatumours  are malignant as per diagnosis report and can be easily reduced by surgery on  the location basis. Therapies like radiation therapy, surgery and chemotherapy are used for this kind of operation. There are  also PEComas which are not curable with surgery and also not recommended for  any kind of therapies.

As per the report, doctor forecast  that advanced malignant PEComa patients  can survive from 12 to 17 months at the time of diagnosis. This is the reason for going for the clinical trial treatment. It  can be improved by reducing the growth of the damaged cell and slow down the tumour process by advanced medicine.